Patients with chronic refractory neuropathic pain who had a spinal cord stimulation device implanted were found to still experience pain relief 2 years later.
A computed tomography-guided pulsed radiofrequency strategy was superior to an injection-only protocol for improving pain and disability scores in patients with acute or subacute neuroradicular low back pain resulting from lumbar disk herniation.
Peripheral nerve stimulation at 10 KHz was found to be efficacious in reducing chronic pain.
Axillary and infraclavicular brachial plexus blocks may have comparable efficacy in preventing and alleviating tourniquet pain associated with moderate-duration repair of fractures distal to the elbow.
Fluoroscope-reported values may overestimate total patient entrance dose-area product used in lumbar epidural injections.
Factors including male gender and high body mass index were found to be independent risk factors for suboptimal interscalene brachial plexus block in patients undergoing arthroscopic elective shoulder arthroscopy.
When used in combination with local anesthetics, dexmedetomidine may increase nerve block-associated analgesia for approximately 5 hours, but use of dexmedetomidine may be associated with a higher risk for intraoperative hypotension and bradycardia.
Several clinical trials have demonstrated the SPRINT PNS System to be effective in reducing pain and improving quality of life.
Sodium bicarbonate-buffered lidocaine may be superior to nonbuffered lidocaine in reducing onset time and injection pain during inferior alveolar nerve block.
Intrathecal drug delivery systems may be ineffective in reducing pain and oral opioid intake in individuals with complex regional pain syndrome.